Net Change In Cash - Skye Bioscience Inc (NASDAQ:SKYE) - Alpha Spread

Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.49 USD 4.77% Market Closed
Market Cap: 154.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Skye Bioscience Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Net Change in Cash
$82.6m
CAGR 3-Years
153%
CAGR 5-Years
145%
CAGR 10-Years
130%
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Skye Bioscience Inc's Net Change in Cash?
Net Change in Cash
82.6m USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Net Change in Cash amounts to 82.6m USD.

What is Skye Bioscience Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
130%

The average annual Net Change in Cash growth rates for Skye Bioscience Inc have been 153% over the past three years , 145% over the past five years , and 130% over the past ten years .

Back to Top